Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
38%
Ph phase_1
3
38%
Ph phase_2
1
13%
Ph phase_3
1
13%

Phase Distribution

3

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
3(37.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(5)

Detailed Status

Completed5
Not yet recruiting1
Enrolling by invitation1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (37.5%)
Phase 21 (12.5%)
Phase 31 (12.5%)
N/A3 (37.5%)

Trials by Status

not_yet_recruiting113%
enrolling_by_invitation113%
completed563%
recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8